These results suggest that EPO can attenuate lung inflammation of LPS-induced ALI by suppressing the NLRP3 inflammasome in a process that depends on the EPOR/JAK2/STAT3/NF-κB signaling axis. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.